Asia Pacific Smart Insulin Pens Market Analysis (2017-2023)

  • ID: 4470053
  • Report
  • Region: Asia, Asia Pacific
  • 85 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 4

FEATURED COMPANIES

  • Companion Medical Inc.
  • DIAMESCO
  • Digital Medics
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • Insulet Corporation
  • MORE
The Asia Pacific Smart Insulin Pen market is expected to witness market growth of 13.2% CAGR during the forecast period (2017 - 2023). Smart insulin pens are used in delivering insulin externally, and as a result, offering better diabetes management system. Insulin pens have gained popularity in the recent years. The demand is due to rapidly rising number of diabetic patients, and cost-effectiveness of the smart insulin pens. In addition, the simple functioning and accurate delivery of appropriate dosing adds to the demand. Nevertheless, some limitations prevail that limit the market growth, such as such as two types of insulin cannot be mixed in an insulin pen, therefore, leading more number of injections.

Smart insulin pens are best in many ways as compared to other insulin delivery devices. These pens are easier to use than syringe and are portable, which makes them easy to be used anywhere. One other benefit of the devices is, it allows dialling the dose accurately, and helping people with vision problems administer insulin easily. These are additional factors that drive the growth of the Smart Insulin Pen market.

Based on type, the market report segments the market into First Generation Pens and Second Generation Pens. Second Generation Pens further sub segmented into Bluetooth-Enabled and USB Connected. The End User covered under the report includes Hospitals & Clinics, Ambulatory Surgical Centers, and Home Care Settings. Based on usability, the market is segmented into prefilled insulin pens and reusable insulin pen. The report also covers country wise segmentation of Smart Insulin Pen market. The countries included in the report are China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the Asia Pacific Smart Insulin Pen Market. Key companies profiled in the report include Companion Medical Inc, Digital Medics Ptd Ltd, Eli Lilly and Company, Novo Nordisk A/S, DIAMESCO, F. Hoffmann-La Roche AG, Insulet Corporation, CardioComm Solutions, Inc., Emperra GmbH E-Health Technologies, and Jiangsu Delfu medical device Co.,Ltd.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Companion Medical Inc.
  • DIAMESCO
  • Digital Medics
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • Insulet Corporation
  • MORE
1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Smart Insulin Pen Market, by Type
1.4.2 Asia Pacific Smart Insulin Pen Market, by Usability
1.4.3 Asia Pacific Smart Insulin Pen Market, by End User
1.4.4 Asia Pacific Smart Insulin Pen Market, by Country
1.5 Methodology for the research

2. Market Overview
2.1 Introduction
2.2 Drivers, Restraints and Opportunities
2.2.1 Market Drivers
2.2.2 Market Restraints

3. Asia Pacific Smart Insulin Pen Market
3.1 Asia Pacific Smart Insulin Pen Market by Product
3.1.1 Asia Pacific Second Generation Smart Insulin Pen by Country
3.1.2 Asia Pacific Second Generation Smart Insulin Pen by Type
3.1.2.1 Asia Pacific Bluetooth-Enabled Smart Insulin Pen Market by Country
3.1.2.2 Asia Pacific USB Connected Smart Insulin Pen Market by Country
3.1.3 Asia Pacific First Generation Smart Insulin Pen by Country

4. Asia Pacific Smart Insulin Pen Market by Usability
4.1 Introduction
4.1.1 Asia Pacific Reusable Smart Insulin Pen by Usability Market by Country
4.1.2 Asia Pacific Prefilled Smart Insulin Pen by Usability Market by Country

5. Asia Pacific Smart Insulin Pen Market by End User
5.1 Introduction
5.1.1 Asia Pacific Hospitals & Clinics Smart Insulin Pen Market by Country
5.1.2 Asia Pacific Ambulatory Surgical Centers Smart Insulin Pen Market by Country
5.1.3 Asia Pacific Home Care Settings Smart Insulin Pen Market by Country

6. Asia Pacific Smart Insulin Pen Market by Country
6.1 China Smart Insulin Pen Market
6.1.1 China Smart Insulin Pen Market by Product
6.1.1.1 China Second Generation Smart Insulin Pen by Type
6.1.2 China Smart Insulin Pen Market by Usability
6.1.3 China Smart Insulin Pen Market by End User
6.2 Japan Smart Insulin Pen Market
6.2.1 Japan Smart Insulin Pen Market by Product
6.2.1.1 Japan Second Generation Smart Insulin Pen by Type
6.2.2 Japan Smart Insulin Pen Market by Usability
6.2.3 Japan Smart Insulin Pen Market by End User
6.3 India Smart Insulin Pen Market
6.3.1 India Smart Insulin Pen Market by Product
6.3.1.1 India Second Generation Smart Insulin Pen by Type
6.3.2 India Smart Insulin Pen Market by Usability
6.3.3 India Smart Insulin Pen Market by End User
6.4 South Korea Smart Insulin Pen Market
6.4.1 South Korea Smart Insulin Pen Market by Product
6.4.1.1 South Korea Second Generation Smart Insulin Pen by Type
6.4.2 South Korea Smart Insulin Pen Market by Usability
6.4.3 South Korea Smart Insulin Pen Market by End User
6.5 Singapore Smart Insulin Pen Market
6.5.1 Singapore Smart Insulin Pen Market by Product
6.5.1.1 Singapore Second Generation Smart Insulin Pen by Type
6.5.2 Singapore Smart Insulin Pen Market by Usability
6.5.3 Singapore Smart Insulin Pen Market by End User
6.6 Malaysia Smart Insulin Pen Market
6.6.1 Malaysia Smart Insulin Pen Market by Product
6.6.1.1 Malaysia Second Generation Smart Insulin Pen by Type
6.6.2 Malaysia Smart Insulin Pen Market by Usability
6.6.3 Malaysia Smart Insulin Pen Market by End User
6.7 Rest of Asia Pacific Smart Insulin Pen Market
6.7.1 Rest of Asia Pacific Smart Insulin Pen Market by Product
6.7.1.1 Rest of Asia Pacific Second Generation Smart Insulin Pen by Type
6.7.2 Rest of Asia Pacific Smart Insulin Pen Market by Usability
6.7.3 Rest of Asia Pacific Smart Insulin Pen Market by End User

7. Company Profiles
7.1 Eli Lilly and Company
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.2 F. Hoffmann-La Roche Ltd
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.3 Companion Medical Inc.
7.3.1 Company Overview
7.4 Digital Medics
7.4.1 Company Overview
7.5 Novo Nordisk A/S
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.6 DIAMESCO
7.6.1 Company Overview
7.7 Insulet Corporation
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.8 CardioComm Solutions, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Emperra GmbH E-Health Technologies
7.9.1 Company Overview
7.1 Jiangsu Delfu medical device Co.,Ltd
7.10.1 Company Overview
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • Companion Medical Inc.
  • Digital Medics
  • Novo Nordisk A/S
  • DIAMESCO
  • Insulet Corporation
  • CardioComm Solutions, Inc.
  • Emperra GmbH E-Health Technologies
  • Jiangsu Delfu medical device Co.,Ltd.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll